A world leader
  in patient-centered care

 

Training the next generation
  of cancer researchers

 

The most advanced
  treatment options available

 

Study shows new cancer drug safe and promising for patients with acute myelogenous leukemia

August 12, 2016

A new study led by Dana-Farber researchers shows Venclexta, the first of a new class of drugs that targets cancer cells’ survival proteins, achieved responses in patients with acute myelogenous leukemia (AML) who had relapsed or were resistant to or couldn’t tolerate chemotherapy.

Susan F. Smith

Remembering Mrs. Susan F. Smith

The Dana-Farber community is deeply saddened by the loss of Mrs. Susan F. Smith, who was a tireless advocate for, and supporter of, women’s cancer care and research. Mrs. Smith was the epitome of hope and action at Dana-Farber and within the wider community. She led by example, encouraged others, and touched countless lives.

Discover Care Believe - boy on pier

"Discover. Care. Believe." highlights Dana-Farber breakthroughs

Dana-Farber Cancer Institute has launched DiscoverCareBelieve.org, a new platform to illustrate what sets Dana-Farber apart — in research discovery... in expert, compassionate care... and in our strong belief in progress for people with cancer everywhere.

Website
Video
What do you #DiscoverCareBelieve?

Charles Fuchs, MD, MPH

New Online Resource for Precision Cancer Medicine

Clinicians at Dana-Farber/Brigham and Women's Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn about the latest thinking in precision cancer medicine from our researchers and clinicians, and explore a searchable database of clinical trials that focus on targeted therapies by disease, gene, and mutation.

Insurance status impacts survival in men with testicular cancer
August 08, 2016

Men with testicular cancer who were uninsured or on Medicaid had a higher risk of death from what is normally a curable disease than insured patients, a new study from Dana-Farber researchers found.

Dana-Farber Cancer Institute monetizes royalty interests derived from immunotherapy patents with Canada Pension Plan Investment Board
August 05, 2016

Dana-Farber Cancer Institute has monetized a portion of its interest in royalties defined by certain licensing agreements related to its Programmed Death Ligand-1 (PD-L1) intellectual property.

U.S. News & World Report names Dana-Farber/Brigham and Women's Cancer Center the best in the region in cancer
August 02, 2016

Dana-Farber/Brigham and Women’s Cancer Center has been named the best for cancer care in New England for the 16th straight year, and fourth overall in the country by U.S. News & World Report.

Stamford Hospital joins Dana-Farber/Brigham and Women’s Cancer Care Collaborative
July 13, 2016

The Stamford Hospital Carl & Dorothy Bennett Cancer Center is the newest member of the Dana-Farber/Brigham and Women’s Cancer Care Collaborative (DF/BWCCC), and the first in Connecticut, Dana-Farber Cancer Institute and Brigham and Women’s Hospital announced today. Participation in the collaborative reflects the Bennett Cancer Center’s demonstrated commitment to excellence by meeting a wide array of standards and best practices.

Women with dense breasts may need annual mammograms (FOX News)

August 23, 2016

Dr. Pamela DiPrio commented on a new study showing women with dense breasts may need yearly breast cancer screening to detect tumors.

Immunotherapy, Vaccines Offer Promise in Glioblastoma, But Data is Still Preliminary (Targeted Therapy)
August 25, 2016

Dr. David Reardon explains why a therapy that provides an impressive and durable benefit has been mostly out of reach for treating brain cancer, particularly glioblastoma.

Study Finds Venetoclax Monotherapy Safe and Clinically Active in AML (ASCO Post)
August 16, 2016

Dr. Anthony Letai led a study showing a new cancer drug is safe and promising for patients with Acute Myelogenous Leukemia or AML.

Patients With Two Different Cancers, Without Insurance Had Higher Death Risk, Studies Find (ABC News)
August 09, 2016

Dr. Christopher Sweeney led a study showing the importance of health insurance for cancer patients.

Immunotherapy Drug Opdivo Fails Clinical Trial to Expand Use (New York Times)
August 08, 2016

Dr. Pasi Janne comments on the failure of a new drug as an initial treatment for patients with lung cancer.

Scientists Raising Their Own Funds For Cancer Research (Huffington Post)
August 04, 2016

Dr. Matthew S. Davids is helping to raise money to fund his own research. It’s a growing trend among doctors and scientists in reaction to the National Institutes of Health budget being flat for a long time.

These Massachusetts hospitals made U.S. News best hospital list (Boston Business Journal)
August 02, 2016

Dana-Farber was named fourth in cancer care in this year's U.S. News and World Report top hospital rankings.

Susan Smith, 83; philanthropist’s passion transformed cancer care (Boston Globe)
August 02, 2016

Dr. Eric Winer talked about how Susan F. Smith helped bring together all of women’s cancers under one umbrella at Dana-Farber.

 

Qigong(1)

August 26, 2016

10:00 AM - 11:30 AM

Smith Building, Room 330

In this class you will learn exercises of the mind/body through mindfulness awareness and fluid movement. These techniques will help you to relax, increase concentration, while utilizing the mind, body and spirit to help improve quality of life. This class is open to patients who have been newly diagnosed with cancer, are receiving treatment, or in remission. Family, friends and staff are welcome. Please call the Zakim Center to register at 617-632-3322 or email Zakim_Center@dfci.harvard.edu.

more

Tai Chi(1)

August 26, 2016

11:30 AM - 1:00 PM

Smith Building, Room 330

This class will focus on gentle movements and exercises. Learn and practice sitting or standing techniques, as well as slow moving meditation focusing on deep breathing and posture to help relax the mind and strengthen the body. This class is open to patients who have been newly diagnosed with cancer, are receiving treatment, or in remission. Family, friends and staff are welcome. Please call the Zakim Center to register at 617-632-3322 or email Zakim_Center@dfci.harvard.edu. more

Mobile Music Open Studio

August 26, 2016

1:30 PM - 2:30 PM

Smith Building, Room 330

Experience the new Mobile Music Studio, and explore how creativity through music is a therapeutic and enriching tool for stress and pain management. Using the technology of a fully functioning recording studio, patients can learn studio basics during our drop-in hours or schedule studio time to write and record your own music. No experience is necessary. This program is led by the Zakim Center's Expressive Therapies manager, Heather Woods, MT-BC. Contact the Leonard P. Zakim Center for Integrative Therapies for any questions: 617-632-3322 or email Zakim_Center@dfci.harvard.edu. more

  •  
  • Patient referral information, clinical resources and more.

  • Make an Appointment


    For adults:
    877-442-3324

    Quick access: Appointments as soon as the next day for new adult patients

    For children:
    888-733-4662


    Make Appointment Online

  • Clinical Trials

    Search current cancer clinical trials at Dana-Farber.

  • How to Help

    Yawkey Center for Cancer Care entrance

    There are many ways to support Dana-Farber and the Jimmy Fund.

    give now button
  • Top-ranked

    • U.S. News Best Hospitals Cancer 2015-2016 logo    U.S. News Best Children's Hospitals Cancer 2015-2016 logo

    Top-ranked cancer center in New England for adults (with Brigham and Women's Hospital) — #1 in the nation for children (with Boston Children's Hospital)

  • Dana-Farber Blog

    Insight Blog screenshot

    Insight features the latest in cancer care and research news from Dana-Farber.
    Read the blog

  • Dana-Farber eNewsletter

    Dana-Farber Spotlight

    Stay current on the latest news by signing up for Spotlight, our email newsletter.
    View current issue
    Subscribe now

8/26/2016 8:33:21 AM